;
Skip to main content
Home > Week in Review > Offerings

Chronological Index of : Financial News

 Current Issue
  • New Science Ventures financial update

    New Science Ventures, New York, N.Y. Business: Finance Date announced: 2014-07-16 Note: New Science Ventures is looking to raise $100 million for its third fund, according to an SEC filing. The firm, which declined to …

    Published on 7/21/2014
  • Seventure Partners financial update

    Seventure Partners, Paris, France Business: Finance Date announced: 2014-06-27 Note: Seventure raised EUR11.5 million ($15.7 million) in a second close of its Health for Life Capital Fund, bringing the total raised to …

    Published on 7/21/2014
  • Siamab Therapeutics financial update

    Siamab Therapeutics Inc., Cambridge, Mass. Business: Cancer, Antibodies Date announced: 2014-07-10 Note: Siamab (formerly Sialix) raised an additional $2 million in a series B round, bringing the total raised in the …

    Published on 7/21/2014
  • Ultragenyx financial update

    Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), Novato, Calif. Business: Musculoskeletal, Endocrine/Metabolic Date announced: 2014-07-14 Note: Ultragenyx raised $12.1 million through the sale of 302,602 shares at $40 to …

    Published on 7/21/2014
  • Wilex financial update

    Wilex AG (Xetra:WL6), Munich, Germany Business: Cancer Date announced: 2014-07-15 Note: Wilex implemented a 1-for-4 reverse stock split. Following the split, the company has 7.8 million shares outstanding.

    Published on 7/21/2014
  • Applied Genetic Technologies proposes follow-on

    Applied Genetic Technologies Corp. (NASDAQ:AGTC), Alachua, Fla. Business: Gene/Cell therapy Date announced: 2014-07-11 Type: Follow-on To be raised: TBD Shares: 2 million Price prior: $19.07 Underwriters: BMO Capital …

    Published on 7/21/2014
  • Phosphagenics proposes private placement

    Phosphagenics Ltd. (ASX:POH; OTCQX:PPGNY), Melbourne, Australia Business: Drug delivery, Neurology Date announced: 2014-07-11 Type: Private placement To be raised: Up to A$3 million ($2.8 million) Shares: 37.5 million …

    Published on 7/21/2014
  • Genocea withdraws follow-on

    Genocea Biosciences Inc. (NASDAQ:GNCA), Cambridge, Mass. Business: Infectious Date announced: 2014-07-16 Type: Follow-on Underwriters: Citigroup; Cowen; Stifel, Nicolaus; Needham Note: The company withdrew a proposed …

    Published on 7/21/2014
  • Atara Biotherapeutics Inc amends IPO

    Atara Biotherapeutics Inc., Brisbane, Calif. Business: Cancer, Renal Date announced: 2014-07-10 Type: IPO To be raised: Up to $80 million Shares: 5 million Price: $14-$16 Underwriters: Goldman Sachs; Citigroup; …

    Published on 7/14/2014
  • CareDx Inc amends IPO

    CareDx Inc., Brisbane, Calif. Business: Diagnostic Date announced: 2014-07-07 Type: IPO To be raised: Up to $53.1 million Shares: 3.1 million Price: $15-$17 Underwriters: Piper Jaffray; Leerink Partners; Raymond James; …

    Published on 7/14/2014
  • Ocular Therapeutix Inc amends IPO

    Ocular Therapeutix Inc., Bedford, Mass. Business: Ophthalmic Date announced: 2014-07-11 Type: IPO To be raised: Up to $80 million Shares: 5 million Price: $14-$16 Underwriters: Morgan Stanley; Cowen; RBC Capital Markets…

    Published on 7/14/2014
  • Pfenex Inc amends IPO

    Pfenex Inc., San Diego, Calif. Business: Biosimilars, Supply/Service Date announced: 2014-07-11 Type: IPO To be raised: Up to $70 million Shares: 5 million Price: $12-$14 Underwriters: William Blair; JMP Securities; …

    Published on 7/14/2014
  • Roka Bioscience Inc amends IPO

    Roka Bioscience Inc., Warren, N.J. Business: Diagnostic Date announced: 2014-07-11 Type: IPO To be raised: Up to $80 million Shares: 5 million Price: $14-$16 Underwriters: BofA Merrill Lynch; Leerink Partners; Cowen; …

    Published on 7/14/2014
  • Sage Therapeutics Inc amends IPO

    Sage Therapeutics Inc., Cambridge, Mass. Business: Neurology Date announced: 2014-07-08 Type: IPO To be raised: Up to $64 million Shares: 4 million Price: $14-$16 Underwriters: JPMorgan; Goldman Sachs; Leerink Partners;…

    Published on 7/14/2014
  • Arch Biopartners Inc completes private placement of units

    Arch Biopartners Inc. (CNSX:ACH), Toronto, Ontario Business: Inflammation, Renal, Cancer Date completed: 2014-07-07 Type: Private placement of units Raised: C$200,200 ($187,467) Units: 715,000 Price: C$0.28 (unit) …

    Published on 7/14/2014
  • arGEN-X N.V completes IPO

    arGEN-X N.V. (Euronext:ARGX), Rotterdam, the Netherlands Business: Antibodies, Cancer, Autoimmune Date completed: 2014-07-08 Type: IPO Raised: EUR40 million ($54.6 million) Shares: 4.7 million Price: EUR8.50 Shares …

    Published on 7/14/2014
  • Auspex Pharmaceuticals Inc completes follow-on

    Auspex Pharmaceuticals Inc. (NASDAQ:ASPX), La Jolla, Calif. Business: Chemistry, Neurology Date completed: 2014-07-11 Type: Follow-on Raised: $60.6 million Shares: 3.2 million Price: $19.25 Shares after offering: 26.8 …

    Published on 7/14/2014
  • Biosceptre International Ltd completes venture financing

    Biosceptre International Ltd., Cambridge, U.K. Business: Cancer Date completed: 2014-07-09 Type: Venture financing Raised: A$5 million ($4.7 million) Investors: Existing investors

    Published on 7/14/2014
  • bluebird bio Inc completes follow-on

    bluebird bio Inc. (NASDAQ:BLUE), Cambridge, Mass. Business: Gene/Cell therapy, Hematology, Neurology Date completed: 2014-07-08 Type: Follow-on Raised: $102 million Shares: 3 million Price: $34 Shares after offering: 27…

    Published on 7/14/2014
  • Cardio3 BioSciences S.A completes private placement

    Cardio3 BioSciences S.A. (Euronext:CARD), Mont-Saint-Guibert, Belgium Business: Cardiovascular Date completed: 2014-07-01 Type: Private placement Raised: EUR12.5 million ($17.1 million) Shares: 284,090 Price: EUR44 …

    Published on 7/14/2014
  • Cerus Corp completes debt financing

    Cerus Corp. (NASDAQ:CERS), Concord, Calif. Business: Cancer, Infectious, Hematology Date completed: 2014-07-01 Type: Debt financing Raised: $10 million Investor: Oxford Finance LLC Note: The company drew down $10 …

    Published on 7/14/2014
  • Cidara Therapeutics Inc completes venture financing

    Cidara Therapeutics Inc., San Diego, Calif. Business: Infectious Date completed: 2014-06-30 Type: Venture financing Raised: $32 million Investors: 5AM Ventures; Aisling Capital; Frazier Healthcare; InterWest Partners; …

    Published on 7/14/2014
  • Durect Corp completes debt financing

    Durect Corp. (NASDAQ:DRRX), Cupertino, Calif. Business: Drug delivery Date completed: 2014-06-26 Type: Debt financing Raised: $20 million Investor: Oxford Finance LLC Note: The loan bears 7.95% interest and matures on …

    Published on 7/14/2014
  • Emerald Therapeutics Inc completes venture financing

    Emerald Therapeutics Inc., Menlo Park, Calif. Business: Supply/Service, Infectious Date completed: 2014-07-01 Type: Venture financing Raised: $6 million Investors: Founders Fund; Schooner Capital; private investor

    Published on 7/14/2014
  • Ergomed Clinical Research Ltd completes IPO

    Ergomed Clinical Research Ltd. (LSE:ERGO), Guilford, U.K. Business: Supply/Service Date completed: 2014-07-09 Type: IPO Raised: L11 million ($18.7 million) Shares: 6.9 million Price: 160p Shares after offering: 28.8 …

    Published on 7/14/2014

< Previous   1  2  3  4  5  6  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993